Noveris Health Sciences is trading at CA$0.04 and is up +12.50%, with no clear catalyst established by the available evidence.
- No company-specific announcement for November 6 was found in the available news results; the latest surfaced company releases were earlier announcements.
- The supplied sector context describes biotech weakness, which does not explain the upward move.